|
Delayed
Bombay S.E.
10:25:03 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 377.45 INR | -0.74% |
|
-4.79% | -8.35% |
| 09-30 | Aarti Drugs Limited Announces Relinquishment of Adhish P. Patil as Chief Financial Officer, Effective September 30, 2026 | CI |
| 09-26 | Aarti Drugs Limited Announces Board Appointments | CI |
Chart: Technical Analysis
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| AARTIDRUGS | Delayed | |
NSE India S.E.
| AARTIDRUGS | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 412.95 | 439.6 | 431.75 |
| Spread/Res. | -8.60% | -14.14% | -12.58% |
| Spread/Supp. | -0.55% | +4.00% | +14.17% |
| Support | 379.55 | 362.95 | 330.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AARTIDRUGS Stock
- Charts Aarti Drugs Limited
Select your edition
All financial news and data tailored to specific country editions
